| Abbreviation | Definition |
| AITL | Angioimmunoblastic T-cell lymphoma |
| ALCL | Anaplastic large cell lymphoma |
| CH | Clonal hematopoiesis |
| CHIP | Clonal hematopoiesis of indeterminate potential |
| CLA | Cutaneous lymphocyte-associated antigen |
| CLL | Chronic lymphocytic leukemia |
| CNV | Copy number variant |
| CTCL | Cutaneous T-cell lymphoma |
| HDACi | Histone deacetylase inhibitor |
| HR | Hazard ratio |
| HSC | Hematopoietic stem cell |
| L-CH | Lymphoid clonal hematopoiesis |
| L-CHIP | Lymphoid clonal hematopoiesis of indeterminate potential |
| mCA | Mosaic chromosomal alteration |
| MF | Mycosis fungoides |
| NER | Nucleotide excision repair |
| NHL | Non-Hodgkin lymphoma |
| NK | Natural killer |
| PTCL | Peripheral T-cell lymphoma |
| SBS7 | Single base substitution signature 7 |
| scRNA-seq | Single-cell RNA sequencing |
| sjTREC | Signal-joint T-cell receptor excision circle |
| SLL | Small lymphocytic lymphoma |
| SS | Sézary syndrome |
| TCM | Central memory T cell |
| TCR | T-cell receptor |
| TRM | Tissue-resident memory T cell |
| UV | Ultraviolet |
| WES | Whole-exome sequencing |
| WTS | Whole-transcriptome sequencing |